Stay updated with breaking news from Nasdaq Vlon. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Vallon Pharmaceuticals, Inc. (NASDAQ:VLON – Get Rating) are going to reverse split on Monday, April 24th. The 1-30 reverse split was announced on Monday, April 24th. The number of shares owned by shareholders will be adjusted after the closing bell on Monday, April 24th. Vallon Pharmaceuticals Price Performance Shares of VLON opened at […]
Vallon’s board approves 1-for-30 reverse stock split Merger expected to close April 21, 2023 PHILADELPHIA, PA, April 20, 2023 (GLOBE NEWSWIRE) --...
Vallon Pharmaceuticals, Inc. (NASDAQ:VLON – Get Rating) was the recipient of a significant drop in short interest in March. As of March 31st, there was short interest totalling 90,700 shares, a drop of 59.6% from the March 15th total of 224,600 shares. Based on an average daily volume of 6,580,000 shares, the short-interest ratio is […]
Vallon Pharmaceuticals, Inc. (NASDAQ:VLON – Get Rating) was the recipient of a large decrease in short interest in March. As of March 15th, there was short interest totalling 224,600 shares, a decrease of 80.1% from the February 28th total of 1,130,000 shares. Based on an average daily trading volume, of 6,710,000 shares, the days-to-cover ratio […]
Vallon Pharmaceuticals (NASDAQ:VLON – Get Rating) and Evelo Biosciences (NASDAQ:EVLO – Get Rating) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, risk, valuation and earnings. Valuation & Earnings This table compares Vallon Pharmaceuticals and […]